Boxer Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-825,000
Closed -$32.5M – 83
2023
Q2
$32.5M Hold
825,000
– – 1.51% 21
2023
Q1
$20.1M Hold
825,000
– – 0.99% 33
2022
Q4
$17.7M Buy
+825,000
New +$17.6M 0.93% 36

Boxer Capital's ISEE Position: Q3 2023 in Review

Boxer Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 825,000 shares — an estimated $32.5M sold.

Boxer Capital first reported a position in ISEE in Q4 2022 and held it in 3 quarters. The position peaked at $32.5M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Boxer Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Boxer Capital sold 825,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $32.5M.
  • Boxer Capital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Boxer Capital's IVERIC bio, Inc. Common Stock position peaked at $32.5M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Boxer Capital's 13F filing for Q3 2023, filed 14 Nov 2023.